clinical researcher in a lab
clinical researcher and consultant collaborating on a trial
couple practicing yoga, representing healthy wellness research

Accelerating development from clinical concept to patient impact through expert clinical research consulting and innovative trial design.
Science-driven. Client-focused. Patient-centered clinical trials.

Synergy Clinical Research Consulting is an independent clinical development consultancy specializing in rare and ultra-rare disease trials. Founded by Debra Lounsbury, a clinical scientist with 20+ years in biopharmaceutical drug development, Synergy provides trial design, medical monitoring, and DMC/SMC leadership for sponsors from early phase through Phase 3.

Known for executing complex programs with rigor and momentum—and for the trusted relationships with sponsors, investigators, KOLs, and patient advocacy groups that move trials forward.

At Synergy Clinical Research Consulting, we deliver expert clinical research consulting and strategic trial leadership that support high-quality, end-to-end clinical trial development—from protocol design through execution and analysis. Our approach integrates robust clinical trial data strategy, seamless collaboration, and scientific rigor to generate trustworthy, decision-enabling evidence that advances innovative therapies for patients with unmet medical needs, including those in rare disease research.

We are your trusted clinical trial consultant, providing expertise in protocol development, KOL and advocacy engagement, participant recruitment and retention, and advanced statistical analysis. We partner with you to deliver patient-centered clinical trials through collaborative clinical trial design and key stakeholder engagement, ensuring every step supports patients and their caregivers, and produces meaningful, decision-enabling evidence.

Together, sharing the goal of advancing science and impacting lives.

What We Do

We offer a wide array of clinical development consulting services including:

Clinical Oversight & Quality Leadership

Clinical Strategy, Evidence Generation & Program Execution

Clinical Data Strategy & Analytics

Extensive Experience in Clinical Development Across Disease States

Experience spans rare and ultra-rare disease—including phenylketonuria (PKU), Pompe disease, MPS IVA, Lambert-Eaton myasthenic syndrome, and vascular Ehlers-Danlos syndrome—as well as oncology, pulmonary fibrosis, sepsis, and pain.

Microscope icon
20+ years

in clinical development

DNA helix icon
Rare disease focus

deep specialization in rare and ultra-rare disease

Molecule icon
Several approved therapies

contributed to globally approved rare disease treatments

Capsule and pill icon
10+ indications

across rare disease, oncology, and critical care

Calendar icon
Phase 1–3

early phase through pivotal trials

Partners In Success Here’s what a few of our clients have to say about working with Synergy

“I found her to be extremely competent, detail-oriented and professional while also maintaining excellent relationships with study investigators…very knowledgeable with regard to regulatory issues and very skilled in her dealing with regulators.”
Barbara K. Burton, MD Professor of Pediatrics | Northwestern University Feinberg School of Medicine | Division of Genetics, Genomics and Metabolism
Ann & Robert H. Lurie Children’s Hospital of Chicago
“We embarked on a challenging clinical development program spanning 17 countries. Initially deemed impossible to execute, Debra’s collaborative and focused approach transformed it into a highly successful study that exceeded recruitment targets ahead of schedule.”
Prof. Christian Hendriksz | Chief Community Impact Officer (Pro bono)
England and Wales registered Charity
“Debra’s sustained and detailed efforts were critical to the execution and success of the pegvaliase clinical trials. Her advice and counsel were key to event management and crucial to the ultimate success of gaining regulatory approval for the drug.”
Cary O. Harding, MD | Professor of Molecular and Medical Genetics
Oregon Health & Science University, Portland OR
“We have worked together on proof of concept, pivotal and label expansion studies in a broad variety of therapeutic areas across the span of treatment modalities. In that time, Debra’s commitment to patient safety, data quality and protocol execution is exemplary. Debra’s consistent application of quality, completeness and execution supports strategic pipeline decision-making.”
David Jacoby, MD, PhD | Senior Vice-President, Head of Clinical Development
Ultragenyx
“Debra sets a high standard for clinical development plans and execution, including collaboration and attentiveness to clinical study needs. High engagement with site PIs assures quick trial recruitment of the appropriate participants, with high uniformity and completeness of data acquisition.”
Peter Slasor ScD | Biostatistician
Executive Director Statistical Science
“Debra is a very knowledgeable and detail-oriented clinical trialist, with patient safety being her top priority. Patients and investigators that have had the opportunity to work with her have shared positive feedback with me regarding her dedication to ensure the clinical trials were conducted minimizing the burden on the patients while collecting high quality data as per the study protocol. I highly support Debra as she is one of the best clinical trialists that I have ever worked with.”
Elaina Jurecki | Director of Research
National PKU Alliance
Scroll to Top